Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Maureen Corcoran, director of the Ohio Department of Medicaid, believes the work requirement policy can be both a financial ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features with type 2 diabetes (T2D), resulting in inappropriate treatment strategies ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after progression on prior treatments. Continuing cemiplimab post-progression can ...

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.